Colorectal cancer metastasis treatment: Difference between revisions

Jump to navigation Jump to search
 
(17 intermediate revisions by 6 users not shown)
Line 1: Line 1:
__NOTOC__
{{Colon cancer}}
{{Colon cancer}}
'''Editor(s)-in-Chief:''' [[C. Michael Gibson]], M.S.,M.D. [mailto:mgibson@perfuse.org]  Phone:617-632-7753; Elliot B. Tapper, M.D., Beth Israel Deaconess Medical Center
{{CMG}} {{AE}}  Saarah T. Alkhairy, M.D.; Elliot B. Tapper, M.D.


==Overview==
==Overview==
When colorectal cancer [[metastasizes]], or travels to other parts of the body, there will be a different approach than a localized [[tumor]].
When colorectal cancer metastasizes, there will be a different approach than with a localized [[tumor]]. The most common site of metastasis is the [[liver]], and the second most common is the [[lung]].


==Metastasis==
==Colorectal Cancer Metastasis==


===Treatment of colorectal cancer metastasis to the liver===
===Treatment of Hepatic Metastasis===
*According to the [[American Cancer Society]] statistics in 2006, greater than 20% of patients present with metastatic (stage IV) colorectal cancer at the time of diagnosis, and up to 25% of this group will have isolated hepatic metastasis that is potentially resectable
*Current [[chemotherapy]] regimens including [[oxaliplatin]] and [[irinotecan]] in addition to [[5-fluorouracil]] (5-FU), and [[leucovorin]] (LV) have achieved improved response rates in colorectal liver metastases<ref name="Misiakos2011">{{cite journal|last1=Misiakos|first1=Evangelos P|title=Current treatment for colorectal liver metastases|journal=World Journal of Gastroenterology|volume=17|issue=36|year=2011|pages=4067|issn=1007-9327|doi=10.3748/wjg.v17.i36.4067}}</ref>
*[[Lesions]] confined to the [[right lobe]] are amenable to en bloc removal with a right [[hepatectomy]] surgery
*Smaller lesions of the central or left liver lobe may sometimes be resected in anatomic "segments", while large lesions of left hepatic lobe are resected by hepatic trisegmentectomy
*Treatment of the lesions by smaller, non-anatomic "wedge" resections, are associated with higher recurrence rates
*Some lesions which are not initially amenable to surgical resection may become candidates if they have significant responses to preoperative [[chemotherapy]] regimens
*Lesions which are not amenable to surgical resection for cure can be treated with modalities including [[radiofrequency ablation]] (RFA), [[cryoablation]], and [[chemoembolization]]
*These patients may be treated in either a single surgery or in staged surgeries (with the colon tumor traditionally removed first) depending upon the fitness of the patient for prolonged surgery and the difficulty expected with the procedure with either the colon or liver resection


According to the [[American Cancer Society]] statistics in 2006 [http://www.cancer.org/docroot/PRO/content/PRO_1_1_Cancer_Statistics_2006_Presentation.asp]greater than 20% of patients present with metastatic (stage IV) colorectal cancer at the time of diagnosis, and up to 25% of this group will have isolated [[liver]] metastasis that is potentially resectable. Lesions which undergo curative resection have demonstrated 5-year survival outcomes now exceeding 50%.<ref> Simmonds PC, et al. Surgical Resection of hepatic metastasis from colorectal cancer: A systemic review of published studies. Br J Surg. 2006;94:982-999. PMID 16538219 </ref>
===Treatment of Pulmonary Metastasis===
*The surgical approach of pulmonary metastases is dictated by the number, size, location, and [[Lobe (anatomy)|lobe]] involved
*The [[bilateral]] thoracosternotomy (“clamshell” incision) involves bilateral submammary thoracotomies with transverse division of the [[sternum]] - this incision provides excellent exposure to the [[hilum]] and all [[Lobe (anatomy)|lobes]] of the [[lung]]<ref name="VilleneuveSundaresan2009">{{cite journal|last1=Villeneuve|first1=P.|last2=Sundaresan|first2=R.|title=Surgical Management of Colorectal Lung Metastasis|journal=Clinics in Colon and Rectal Surgery|volume=22|issue=04|year=2009|pages=233–241|issn=1531-0043|doi=10.1055/s-0029-1242463}}</ref>


[[Resectability]] of a liver met is determined using preoperative imaging studies (Ct or MRI), [[intraoperative ultrasound]], and by direct [[palpation]] and visualization during resection. [[Lesions]] confined to the [[right lobe]] are amenable to en bloc removal with a right [[hepatectomy]] (liver resection) surgery. Smaller lesions of the central or left liver lobe may sometimes be resected in anatomic "segments", while large lesions of left hepatic lobe are resected by a procedure called [[hepatic trisegmentectomy]]. Treatment of lesions by smaller,non-anatomic "wedge" resections is associated with higher recurrence rates. Some lesions which are not initially amenable to surgical resection may become candidates if they have significant responses to preoperative [[chemotherapy]] or [[immunotherapy]] regimines. Lesions which are not amenable to surgical resection for cure can be treated with modalities including [[radio-frequency ablation]] (RFA), [[cryoablation]], and [[chemoembolization]].
*VATS procedures are rapidly gaining popularity - they utilize [[laparoscopic]]-style instruments introduced via trocars resulting in smaller incisions and reduced postoperative morbidity<ref name="VilleneuveSundaresan2009">{{cite journal|last1=Villeneuve|first1=P.|last2=Sundaresan|first2=R.|title=Surgical Management of Colorectal Lung Metastasis|journal=Clinics in Colon and Rectal Surgery|volume=22|issue=04|year=2009|pages=233–241|issn=1531-0043|doi=10.1055/s-0029-1242463}}</ref>


Patients with colon cancer and metastatic disease to the liver may be treated in either a single surgery or in staged surgeries (with the colon tumor traditionally removed first) depending upon the fitness of the patient for prolonged surgery, the difficulty expected with the procedure with either the colon or liver resection, and the comfort of the surgery performing potentially complex [[hepatic surgery]].  
The table below depicts the patterns of pulmonary metastatic spread and the suggested operative approach:<ref name="VilleneuveSundaresan2009">{{cite journal|last1=Villeneuve|first1=P.|last2=Sundaresan|first2=R.|title=Surgical Management of Colorectal Lung Metastasis|journal=Clinics in Colon and Rectal Surgery|volume=22|issue=04|year=2009|pages=233–241|issn=1531-0043|doi=10.1055/s-0029-1242463}}</ref>


Poor prognostic factors of patients with liver metastasis include
{| style="border:#c9c9c9 1px solid; margin: 1em 1em 1em 0; border-collapse: collapse;" cellspacing="0" cellpadding="4" {{table}}
* [[Synchronous]] (diagnosed simultaneously) liver and primary colorectal tumors
* A short time between detecting the primary cancer and subsequent development of liver mets
* Multiple metastatic lesions
* High [[blood]] levels of the tumor marker, [[carcino-embryonic antigen]] ('''CEA'''), in the patient prior to resection
* Larger size metastatic lesions


| style="background:#f0f0f0;" align="center" |'''Nodule Characteristics'''
| style="background:#f0f0f0;" align="center" |'''Thoracotomy'''
| style="background:#f0f0f0;" align="center" |'''VATS'''
|-
| '''Number''' ||>3||3-Jan
|-
| '''Size (cm)'''||>4||<1.5
|-
| '''Location'''||Central||Peripheral
|-
| '''Lobe'''||Lower||Upper, middle
|}
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
[[Category:Disease]]
[[Category:Gastroenterology]]
[[Category:Types of cancer]]
[[Category:Conditions diagnosed by stool test]]
[[Category:Mature chapter]]
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Gastroenterology]]
[[Category:Surgery]]

Latest revision as of 15:08, 18 December 2017

Colorectal cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Colorectal cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Metastasis Treatment

Primary Prevention

Secondary Prevention

Follow-up

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Colorectal cancer metastasis treatment On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Colorectal cancer metastasis treatment

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Colorectal cancer metastasis treatment

CDC on Colorectal cancer metastasis treatment

Colorectal cancer metastasis treatment in the news

Blogs on Colorectal cancer metastasis treatment

Directions to Hospitals Treating Colorectal cancer

Risk calculators and risk factors for Colorectal cancer metastasis treatment

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Saarah T. Alkhairy, M.D.; Elliot B. Tapper, M.D.

Overview

When colorectal cancer metastasizes, there will be a different approach than with a localized tumor. The most common site of metastasis is the liver, and the second most common is the lung.

Colorectal Cancer Metastasis

Treatment of Hepatic Metastasis

  • According to the American Cancer Society statistics in 2006, greater than 20% of patients present with metastatic (stage IV) colorectal cancer at the time of diagnosis, and up to 25% of this group will have isolated hepatic metastasis that is potentially resectable
  • Current chemotherapy regimens including oxaliplatin and irinotecan in addition to 5-fluorouracil (5-FU), and leucovorin (LV) have achieved improved response rates in colorectal liver metastases[1]
  • Lesions confined to the right lobe are amenable to en bloc removal with a right hepatectomy surgery
  • Smaller lesions of the central or left liver lobe may sometimes be resected in anatomic "segments", while large lesions of left hepatic lobe are resected by hepatic trisegmentectomy
  • Treatment of the lesions by smaller, non-anatomic "wedge" resections, are associated with higher recurrence rates
  • Some lesions which are not initially amenable to surgical resection may become candidates if they have significant responses to preoperative chemotherapy regimens
  • Lesions which are not amenable to surgical resection for cure can be treated with modalities including radiofrequency ablation (RFA), cryoablation, and chemoembolization
  • These patients may be treated in either a single surgery or in staged surgeries (with the colon tumor traditionally removed first) depending upon the fitness of the patient for prolonged surgery and the difficulty expected with the procedure with either the colon or liver resection

Treatment of Pulmonary Metastasis

  • The surgical approach of pulmonary metastases is dictated by the number, size, location, and lobe involved
  • The bilateral thoracosternotomy (“clamshell” incision) involves bilateral submammary thoracotomies with transverse division of the sternum - this incision provides excellent exposure to the hilum and all lobes of the lung[2]
  • VATS procedures are rapidly gaining popularity - they utilize laparoscopic-style instruments introduced via trocars resulting in smaller incisions and reduced postoperative morbidity[2]

The table below depicts the patterns of pulmonary metastatic spread and the suggested operative approach:[2]

Nodule Characteristics Thoracotomy VATS
Number >3 3-Jan
Size (cm) >4 <1.5
Location Central Peripheral
Lobe Lower Upper, middle

References

  1. Misiakos, Evangelos P (2011). "Current treatment for colorectal liver metastases". World Journal of Gastroenterology. 17 (36): 4067. doi:10.3748/wjg.v17.i36.4067. ISSN 1007-9327.
  2. 2.0 2.1 2.2 Villeneuve, P.; Sundaresan, R. (2009). "Surgical Management of Colorectal Lung Metastasis". Clinics in Colon and Rectal Surgery. 22 (04): 233–241. doi:10.1055/s-0029-1242463. ISSN 1531-0043.


Template:WikiDoc Sources